Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical Labs
Diagnostics · 21.03.2025 · 15 (7) · 794
DOI: 10.3390/diagnostics15070794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 21.03.2025. Verfasst von Jeffrey L Bessen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health Advances LLC, Newton, MA 02466, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca (United States), AstraZeneca US Medical Affairs.
Abstract (Originalsprache)
Background/Objectives: Digital and computational pathology (DP/CP) tools have the potential to improve the efficiency and accuracy of the anatomic pathology workflow; however, current adoption among US hospital and reference labs remains low.
Methods
To better understand the current utilization of DP/CP technology and barriers to widespread adoption, we conducted a survey among 63 anatomic pathologists and lab directors within the US health system.
Results
The survey results indicated that current use cases for DP/CP involve streamlining traditional manual pathology and that labs would have substantial difficulty providing AI-guided image analysis if it were required by physicians today. Among potential catalysts for the broader adoption of DP/CP, pathologists identified clinical guidelines as a key resource for anatomic pathology, whose endorsement of DP/CP would be highly impactful for reducing current barriers.
Conclusions
Expanded access to DP/CP may ultimately benefit all major stakeholders—patients, physicians, clinical laboratory professionals, care settings, and payers—and will therefore require collaboration across these groups.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Advances LLC, Newton, MA 02466, USA.
- AstraZeneca, Gaithersburg, MD 20878, USA.
ORCID-Profile: Jeffrey L Bessen, Gary Gustavsen
Förderung
- AstraZeneca (United States)
- AstraZeneca US Medical Affairs
Zitieren
APA
Bessen, J. L., Alexander, M., Foroughi, O., Brathwaite, R., Baser, E., Lee, L. C., Perez, O., & Gustavsen, G. (2025). Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical Labs. Diagnostics, 15(7), 794. https://doi.org/10.3390/diagnostics15070794
Vancouver
Bessen JL, Alexander M, Foroughi O, Brathwaite R, Baser E, Lee LC, et al. Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical Labs. Diagnostics. 2025;15(7):794. doi:10.3390/diagnostics15070794
BibTeX
@article{Bessen2025,
author = {Bessen, Jeffrey L and Alexander, Melissa and Foroughi, Olivia and Brathwaite, Roderick and Baser, Emre and Lee, Liam C and Perez, Omar and Gustavsen, Gary},
title = {Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical Labs},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {7},
pages = {794},
doi = {10.3390/diagnostics15070794}
}
EUVIMED